CURE - Oncology & Cancer News for Patients & Caregivers
CURE - Oncology & Cancer News for Patients & Caregivers
Spotlight
BlogsClinical Trial CornerCURE's 20th Anniversary CelebrationPodcastsPublicationsRecipesVideos
Cancer Type
View MoreBladderBreastCLLKidneyLungMCLOvarianProstateSkin
About CURE
Press ReleasesShare Your StoryWrite for CURE
News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections
CURE Speaking Out
CURE TV
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
Award Programs
Educated Patient Summits
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
Clinical Trial Corner
CURE Ambassador Program
Educated Patient Research Updates
Interactive Tools
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information

© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Spotlight
  • Blogs
  • Clinical Trial Corner
  • CURE's 20th Anniversary Celebration
  • Podcasts
  • Publications
  • Recipes
  • Videos
Cancer TypeSee All >
  • Bladder
  • Breast
  • CLL
  • Kidney
  • Lung
  • MCL
  • Ovarian
  • Prostate
  • Skin
About CURE
  • Press Releases
  • Share Your Story
  • Write for CURE
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Understanding PARP Inhibition in BRCA-Mutated Breast Cancer

EP. 1: Appropriately Diagnosing and Classifying Breast Cancer

December 4th 2018

EP. 2: Considering Treatment for HER2-Negative Breast Cancer

December 4th 2018

EP. 3: BRCA Mutations in HER2-Negative Breast Cancer

December 4th 2018

EP. 4: BRCA+ Breast Cancer: The Advent of PARP Inhibitors

December 4th 2018

EP. 5: Future Role of PARP Inhibition in BRCA+ Breast Cancer

December 4th 2018

EP. 6: Breaking Down the Nature of Breast Cancer

December 4th 2018

EP. 7: Breast Cancer Diagnosis: Addressing Questions and Concerns

December 4th 2018

EP. 8: Treatment Options for HER2-Negative Breast Cancer

December 4th 2018

EP. 9: Benefit of PARP Inhibitors in BRCA+ Breast Cancer

December 4th 2018

EP. 10: BRCA+ Breast Cancer: Managing Patients on PARP Inhibitors

December 4th 2018

EP. 11: Multidisciplinary Management of Breast Cancer

December 4th 2018

EP. 12: Future Treatment Options for BRCA+ Breast Cancer

December 4th 2018

Latest News

Myelofibrosis Symptom Management Is ‘Incredibly Important’ to Preserve Quality of Life

Educated Patient® MPN Summit Disease Approaches Panel: May 7, 2022

I Wouldn't Have Gotten Through My Cancer Journey Without My Amazing Oncology Nurse, My Sister

Do You Ever Question Your Cancer Care?

View More Latest News